Hemopoietic progenitor cells ave sensitive targets of 2,3,7,8-tetrachlorodibenzo-p-dioxin in C57BL/6J mice

被引:32
作者
Murante, FG [1 ]
Gasiewicz, TA [1 ]
机构
[1] Univ Rochester, Med Ctr, Dept Environm Med, Rochester, NY 14642 USA
关键词
tetrachlorodibenzo-p-dioxin; TCDD; hemopoiesis; Sca-1; c-Kit; hemopoietic stem cells; flow cytometry;
D O I
10.1093/toxsci/54.2.374
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Treatment of adult C57BL/6J mite with tetrachlorodibenzo-p-dioxin (TCDD) elicits altered bone marrow hemopoietic cellular potentials and markedly reduced T-lymphoid-reconstituting activity. The latter has been hypothesized to play a role in TCDD-induced thymic atrophy. To investigate cellular targets responsible for reduced prothymocyte capacity, bone marrow cells from TCDD-treated C57BL/6J mice were assessed for hemopoietic alterations within the lineage-negative (lin(-)) compartment by the examination of Sca-1 and c-Kit levels. Lin(-) hemopoietic cells from C57BL/6J mice, treated dth 30 mu g/kg of TCDD, were assessed for phenotypic alterations following 24 h through 31 days. The responses of lin(-) cells to TCDD doses ranging from 0.3 to 30 mu g/kg were also assessed at 2 days following TCDD treatment. The data reveal increases in the number of bone marrow lin(-) Sca-1(+) c-Kit(+) cells, relative to control, over 24 h through 31 days following treatment, as well as dose-dependent increases in this population when examined at 2 days. Increases in Lin(-) Sca-1(+) c-Kit(+) cells occurred on a more transient basis and were also dependent upon TCDD dose. These data suggest that proliferation and/or differentiation processes of hemopoietic stem cells are affected by TCDD and that these effects contribute to a reduced capacity of bone marrow to generate pro-T lymphocytes.
引用
收藏
页码:374 / 383
页数:10
相关论文
共 64 条
[1]  
ANTICA M, 1993, J IMMUNOL, V151, P5887
[2]  
ANTICA M, 1994, BLOOD, V84, P111
[3]   ASSESSMENT OF MYELOTOXICITY CAUSED BY ENVIRONMENTAL CHEMICALS [J].
BOORMAN, GA ;
LUSTER, MI ;
DEAN, JH ;
CAMPBELL, ML .
ENVIRONMENTAL HEALTH PERSPECTIVES, 1982, 43 (FEB) :129-135
[4]  
Bradford GB, 1997, EXP HEMATOL, V25, P445
[5]  
Brenner DA, 1996, HEPATOLOGY, V23, P379
[6]   TIME-COURSE OF 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN (TCDD)-INDUCED THYMIC ATROPHY IN THE WISTAR RAT [J].
DEHEER, C ;
VERLAAN, APJ ;
PENNINKS, AH ;
VOS, JG ;
SCHUURMAN, HJ ;
VANLOVEREN, H .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1994, 128 (01) :97-104
[7]   COMPARISONS OF ESTIMATED HUMAN-BODY BURDENS OF DIOXINLIKE CHEMICALS AND TCDD BODY BURDENS IN EXPERIMENTALLY EXPOSED ANIMALS [J].
DEVITO, MJ ;
BIRNBAUM, LS ;
FARLAND, WH ;
GASIEWICZ, TA .
ENVIRONMENTAL HEALTH PERSPECTIVES, 1995, 103 (09) :820-831
[8]   DOSE-RESPONSE RELATIONSHIPS OF TISSUE DISTRIBUTION AND INDUCTION OF CYP1A1 AND CYP1A2 ENZYMATIC-ACTIVITIES FOLLOWING ACUTE EXPOSURE TO 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN (TCDD) IN MICE [J].
DILIBERTO, JJ ;
AKUBUE, PI ;
LUEBKE, RW ;
BIRNBAUM, LS .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1995, 130 (02) :197-208
[9]   Transforming growth factor-β1 coregulates mRNA expression of aryl hydrocarbon receptor and cell-cycle-regulating genes in human cancer cell lines [J].
Döhr, O ;
Abel, J .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 241 (01) :86-91
[10]   IMMUNE-SYSTEM IMPAIRMENT AND HEPATIC-FIBROSIS IN MICE LACKING THE DIOXIN-BINDING AH RECEPTOR [J].
FERNANDEZSALGUERO, P ;
PINEAU, T ;
HILBERT, DM ;
MCPHAIL, T ;
LEE, SST ;
KIMURA, S ;
NEBERT, DW ;
RUDIKOFF, S ;
WARD, JM ;
GONZALEZ, FJ .
SCIENCE, 1995, 268 (5211) :722-726